ROCHESTER MEDICAL SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Rochester Medical Corporation In Connection With Sale Of The Company

Levi & Korsinsky is investigating the Board of Directors of Rochester Medical Corporation (“Rochester” or the “Company”) (NasdaqGM: ROCM) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to C. R. Bard, Inc.

Click here to learn more about the investigation http://zlk.9nl.com/rochester-medical-rocm/, or call: 877-363-5972. There is no cost or obligation to you.

Under the terms of the transaction, Rochester shareholders will receive $20 for each share of Rochester stock they own. The transaction has a total approximate value of $262 million. The investigation concerns whether the Rochester Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether C. R. Bard, Inc. is underpaying for Rochester shares.

If you own Rochester common stock and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/rochester-medical-rocm/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

Copyright Business Wire 2010

If you liked this article you might like

Rochester Medical Corporation Stock Upgraded (ROCM)

Rochester Medical Corporation's CEO Discusses Q3 2012 Results - Earnings Call Transcript

Rochester Medical Corporation's CEO Discusses Q2 2012 Results - Earnings Call Transcript

Rochester Medical Corporation Stock Upgraded (ROCM)

Rochester Medical CEO Discusses F1Q2012 Results - Earnings Call Transcript